Cancer medicines

Pertuzumab

Pertuzumab

An antibody used in combination treatment for HER2-positive breast cancer.

Sources checked · Introductory guide

On this page

How it works

It binds HER2 and inhibits receptor pairing and growth signaling.[3]

Where it is used

Combined with other anti-HER2 medicines or chemotherapy in selected perioperative or metastatic HER2-positive breast cancer settings.[1]

Key safety points

Heart function is monitored before and during treatment. Report new breathlessness, swelling, rapid weight gain or infusion reactions immediately.[2]

Questions for your care team

  • What are my HER2 result, combination medicines and heart ultrasound schedule?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Pertuzumab (opens in a new tab)
  2. MedlinePlus · Pertuzumab (opens in a new tab)
  3. NCI Drug Dictionary · Pertuzumab (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Pertuzumab | Cancer Encyclopedia | My Chemo Diary